Algae microbots take aim at bladder cancer

Researchers at the University of Edinburgh in the UK and Xiamen University in China have developed algae-based magnetic microrobots that significantly improve delivery of chemotherapy drugs into bladder tumors in mice, potentially paving the way for more effective and less invasive bladder cancer treatment worldwide¹.

Tiny algae robots boost chemotherapy delivery

The new biohybrid microrobots are engineered from natural, single-celled microalgae and loaded with the chemotherapy drug doxorubicin. Guided by externally programmed magnetic fields and tracked using real-time ultrasound imaging, the microrobots can be directed to bladder tumors, where they help drugs penetrate deep into tumor tissue while limiting damage to healthy cells.

In laboratory tests with mice, this targeted drug delivery approach increased drug penetration by more than ten times compared with standard intravesical chemotherapy. After one week of therapy, tumor burden was reduced to less than three per cent of that seen in the conventional treatment group.

Addressing limitations of current bladder cancer therapies

Bladder cancer is among the ten most common cancers worldwide and is often treated with surgery to remove the tumor followed by direct drug instillation, in which chemotherapy drugs are delivered into the bladder through a catheter. However, these drugs frequently struggle to penetrate deeply into tumor tissue, limiting their effectiveness and often requiring longer treatment times or higher doses.

The new microrobot technology is designed to overcome these biological barriers to drug penetration. By enhancing the efficiency of local chemotherapy delivery, the approach could reduce overall drug exposure while improving treatment effectiveness and shortening therapy sessions.

Biohybrid microrobots engineered from natural microalgae

The microrobots are based on tablet-like microalgae that are naturally biocompatible and biodegradable, making them suitable for safe use in the body. Their delicate nanoporous structure is well suited for secure packaging and controlled release of chemotherapy drugs.

According to the research team, the microalgae are abundant in nature, cost-effective and suitable for scalable production, supporting the potential for future clinical translation. Once loaded with doxorubicin, the algae-based microrobots can be remotely guided through the bladder using magnetic fields.

Real-time imaging enables precise, targeted drug delivery

Using real-time ultrasound imaging feedback, researchers can precisely control how the swarm of drug-loaded microrobots moves inside the bladder. By adjusting the magnetic fields, the team can cause the microrobots to roll and rotate, switching between transport and release modes to achieve targeted drug delivery across the tumor.

The coordinated motion of the microrobots through narrow spaces within tumor tissue has been likened to schools of fish or flocks of birds moving together, enabling rapid and efficient distribution of chemotherapy throughout the tumor mass.

Promising preclinical results in mouse models

In mouse models of bladder cancer, the algae-based microrobots delivered doxorubicin rapidly and efficiently across the tumor while minimising side effects. The treatment in mice can be completed in around 30 minutes, compared with the much longer exposure times often required for conventional intravesical chemotherapy.

Researchers say the improved therapeutic effect could support less invasive strategies for the treatment of bladder cancer, although further preclinical studies and regulatory review will be needed before clinical trials can begin.

Expert perspectives on microrobot-guided chemotherapy

Study co-lead Dr. Qi Zhou, Lecturer in Biomedical Informatics at the University of Edinburgh’s Institute for Neuroscience and Cardiovascular Research, said, “Our microrobots are engineered from tablet-like microalgae, can be remotely guided to the tumor using real-time imaging feedback, and release drugs exactly where they are needed to drive rapid tissue penetration in a minimally invasive way.”

Professor Xiaohui Yan, from Xiamen University in China, said, “This study highlights a non-invasive approach to overcoming the biological barriers that limit drug penetration in bladder tumors. We are now discussing translational follow-up studies with hospitals, with the long-term aim of clinical trials after further preclinical validation and regulatory review.”

References

1. Lin, L., Li, H., Zhou, Q. et al. Machine-intelligent multimodal algebot for intracavitary chemotherapy. Nat. Nanotechnol. (2026). https://doi.org/10.1038/s41565-026-02195-0

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>